Učitavanje...
Cerebrospinal fluid GAP-43 in early multiple sclerosis
BACKGROUND/OBJECTIVE: Novel biomarkers identifying and predicting disease activity in multiple sclerosis (MS) would be valuable for primary diagnosis and as outcome measures for monitoring therapeutic effects in clinical trials. Axonal loss is present from the earliest stages of MS and correlates wi...
Spremljeno u:
| Izdano u: | Mult Scler J Exp Transl Clin |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6081760/ https://ncbi.nlm.nih.gov/pubmed/30094057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217318792931 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|